Abstract
The Impact of Cardiovascular Prevention on the Cost Benefit of Influenza Vaccination for Australian Adults aged 50–64 years old
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have